- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02643797
Medical Assistant Health Coaching for Diabetes in Diverse Primary Care Settings (MAC)
September 20, 2021 updated by: Athena Philis-Tsimikas, Scripps Whittier Diabetes Institute
This study is a cluster (clinic level) randomized pragmatic trial to compare the effectiveness of MA Health Coaching (MAC) delivered by non-clinician primary care staff (i.e., MAs) versus usual care (UC) in improving diabetes clinical control among individuals with poorly controlled type 2 diabetes mellitus (T2DM).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study will be conducted in the primary care environments of two distinct, yet representative healthcare systems in San Diego County: Neighborhood Healthcare (a San Diego County FQHC system and designated Patient-Centered Medical Home, serving predominantly ethnic minority, low income patients) and Scripps (a large, non-profit, private insurance-based health system, serving predominantly Caucasian, middle-to-higher income patients).
Six hundred patients at intervention (n=2; patient N=300) and control (n=2; patient N=300) clinics, aged 18 and older, with T2DM, and glycosylated hemoglobin (HbA1c) ≥ 8.0%, and/or low-density lipoprotein cholesterol (LDL-C) ≥ 100 mg/dL, and/or systolic blood pressure (SBP) ≥ 140 within the last 60 days, will be identified and enrolled using electronic health records (EHRs).
Primary clinical outcomes of HbA1c, LDL-C, and SBP assessed as part of quarterly (or annual, for LDL-C), standard-of-care medical visits will be extracted from EHRs over 12 months.
Changes in patient-reported behavioral (diabetes self-care) and psychosocial (quality of life, patient activation) outcomes will be evaluated via telephone assessment in a subset of intervention and control (N=300 total) participants at baseline, month 6, and month 12.
A thorough process evaluation will be conducted to establish reach, acceptability/feasibility, adoption/maintenance, and fidelity of the intervention and will integrate patient, MA, and primary care provider perspectives.
Cost-effectiveness will also be examined from the health system perspective.
Principles of community engaged research were incorporated in intervention and study planning and will be sustained throughout the research period.
Study Type
Interventional
Enrollment (Actual)
602
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
La Jolla, California, United States, 92121
- Scripps Whittier Diabetes Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Must be a patient at selected Scripps or Neighborhood Healthcare clinic,
- Must be age 18 years or older,
- Must have a T2DM diagnosis,
- Must show evidence of poor clinical control, defined as HbA1c ≥ 8% and/or LDL-C ≥ 100 mg/dL, and/or SBP ≥ 140 mmHg.
Exclusion Criteria:
None as this is a pragmatic trial.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group: MA Health Coaching
Patients in the intervention group will receive the "MA Health Coaching" intervention during their primary care visits, as well a follow-up calls to encourage/monitor progress and offer support.
|
One-on-one behavioral health screening and tailored intervention by the MA health coach with patients who have type 2 diabetes.
Other Names:
|
|
No Intervention: Usual Care
Patients in this group will receive "treatment as usual" during their primary care visits.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Glycosylated Hemoglobin (Hba1c); % units
Time Frame: 12 months
|
12 months
|
|
Low-density lipoprotein-cholesterol (LDL-c); mg/dL units
Time Frame: 12 months
|
12 months
|
|
Systolic blood pressure (SBP); mmHg units
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Summary of Diabetes Self-Care Activities (SDSCA) - patient-reported outcome
Time Frame: 12 months
|
12 months
|
|
Patient Activation Measure (PAM) - patient-reported outcome
Time Frame: 12 months
|
12 months
|
|
Patient Reported Outcomes Measurement Information System (PROMIS) General Health Scale - patient-reported outcome
Time Frame: 12 months
|
12 months
|
|
Patient Assessment of Care for Chronic Conditions (PACIC) - patient-reported outcome
Time Frame: 12 months
|
12 months
|
|
Morisky Medication Adherence Scale (MMAS) - patient-reported outcome
Time Frame: 12 months
|
12 months
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cost-effectiveness using the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Linda Gallo, PhD, San Diego State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 7, 2016
Primary Completion (Actual)
April 19, 2020
Study Completion (Actual)
April 19, 2020
Study Registration Dates
First Submitted
November 30, 2015
First Submitted That Met QC Criteria
December 28, 2015
First Posted (Estimate)
December 31, 2015
Study Record Updates
Last Update Posted (Actual)
September 27, 2021
Last Update Submitted That Met QC Criteria
September 20, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R18DK104250-01A1 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes Mellitus (T2DM)
-
Embecta Corp.Jaeb Center for Health ResearchWithdrawnType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | T2DM (Type 2 Diabetes Mellitus) | T2D | T2DM | Type 2 DM | T2DM With Inadequate Glycemic ControlUnited States
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
Thymia LimitedCompletedType 2 Diabetes | Diabetes (DM) | T2DM (Type 2 Diabetes Mellitus) | T2DMUnited Kingdom
-
University of Colorado, DenverAmerican Academy of Family PhysiciansRecruitingType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | T2DM (Type 2 Diabetes Mellitus) | T2D | T2DM | Artificial Intelegence | Remote Patient MonitoringUnited States
-
Beijing HospitalRecruitingType 2 Diabetic Patients | T2DM (Type 2 Diabetes Mellitus) | T2DMChina
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
University of PennsylvaniaNational Institute on Aging (NIA); American Heart AssociationRecruitingType 2 Diabetes Mellitus | Type 2 Diabetes | Type II Diabetes Mellitus | Pre-diabetes | Pre-diabetic | Type II Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2DM) | Pre-diabetic StateUnited States
-
The Third Xiangya Hospital of Central South UniversityNot yet recruiting
-
Hanmi Pharmaceutical Company LimitedRecruitingType 2 Diabetes Mellitus | T2DMUnited States
-
yueh chu wuRecruitingType 2 Diabetes Mellitus (T2DM)Taiwan
Clinical Trials on Medical Assistant Health Coaching
-
University of California, San FranciscoCompletedHypertension | Diabetes | HyperlipidemiaUnited States
-
University of Alabama at BirminghamNational Institute on Minority Health and Health Disparities (NIMHD)CompletedHypertension | Obesity | PreDiabetes | Prehypertension | Type 2 Diabetes | DyslipidemiaUnited States
-
Alma Phil GmbhCompletedOther Secondary Hypertension | Secondary Hypertension, Unspecified | Syncope and Collapse | Dizziness and Giddiness | Essential (Primary) Hypertension | Hypertensive Heart Disease With (Congestive) Heart Failure | Hypertensive Heart Disease Without (Congestive) Heart FailureGermany
-
Alma Phil GmbhCompletedHealth | Health Care Delivery | Mobility and Independence | Care of the Elderly | Care GiversGermany
-
Mayo ClinicRecruitingWellbeingUnited States
-
Habit DesignUniversity of Washington; TriHealth Inc.Recruiting
-
Beijing Anzhen HospitalNot yet recruitingCongenital Heart Disease | Aortic Aneurysm | Aortic Dissection | Heart Valve Disease | Coronary Artery Bypass Grafting | Cardiac Surgical ProceduresChina
-
Last Mile HealthMassachusetts General Hospital; Northwestern University; Georgetown University; Heidelberg UniversityActive, not recruitingDiarrhea | Malaria | Acute Respiratory Infection | Malnutrition, ChildLiberia
-
University of California, San FranciscoKaiser PermanenteCompleted
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingHealth Behavior | Type2 Diabetes Mellitus